Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?-Reference-Cited by-同舟云学术

Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?

Published:2018 Issue:2 Volume:29 Page:
ISSN:2005-0380
Container-title:Journal of Gynecologic Oncology
language:en
Short-container-title:J Gynecol Oncol

Author:

Yamagami Wataru¹^ORCID,Susumu Nobuyuki¹²^ORCID,Makabe Takeshi¹^ORCID,Sakai Kensuke¹^ORCID,Nomura Hiroyuki¹^ORCID,Kataoka Fumio¹^ORCID,Hirasawa Akira¹^ORCID,Banno Kouji¹^ORCID,Aoki Daisuke¹^ORCID

Affiliation:

1. Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.

2. Department of Obstetrics and Gynecology, International University of Health and Welfare, Otawara, Japan.

Funder

Japan Society for the Promotion of Science

Publisher

Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy

Subject

Obstetrics and Gynecology,Oncology,General Medicine

Link

https://synapse.koreamed.org/pdf/10.3802/jgo.2018.29.e21

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advantages of Robotic Surgery for Patients of Reproductive Age with Endometrial Cancer;Life;2024-09-03

2. Reproductive and transcriptome characteristics of endometrium at the window of im-plantation in patients after fertility-sparing treatment of endometrial intraepithelial neoplasm or cancer;Heliyon;2024-08

3. Fertility-sparing re-treatment for endometrial cancer and atypical endometrial hyperplasia patients with progestin-resistance: a retrospective analysis of 61 cases;World Journal of Surgical Oncology;2024-06-25

4. A phase II trial evaluating the efficacy and safety of repeated high dose medroxyprogesterone acetate (MPA) therapy for patients with recurrent early-stage endometrial cancer or atypical endometrial hyperplasia: Japanese Gynecologic Oncology Group study (JGOG2051/KGOG2031, REMPA trial);Journal of Gynecologic Oncology;2024

5. Analysis of risk factors for recurrence in infertile endometrial cancer patients after in vitro fertilization treatment;Frontiers in Endocrinology;2023-11-22